Position in ORIC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,001,728
+$366,093 QoQ
Shares Held
79,063
+1.7% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 15.996104372462467.ToString("F0")%
Shared 0.ToString("F0")%
None 84.00389562753753.ToString("F0")%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,828,718 across 284 Biotechnology names. ORIC ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ORIC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,001,728 | 79,063 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $635,635 | 77,706 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $984,372 | 82,031 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $725,024 | 71,431 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $495,241 | 88,753 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $753,084 | 93,319 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $914,781 | 89,247 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $655,403 | 92,702 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $829,125 | 60,300 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $532,716 | 57,904 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $354,415 | 58,581 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $402,782 | 51,905 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $207,571 | 38,871 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $528,465 | 35,950 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $760,120 | 36,352 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $597,462 | 33,774 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $550,931 | 22,487 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $744,429 | 21,992 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $217,186 | 8,684 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $340,976 | 10,109 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||